Description
The Centers for Disease Control and Prevention (CDC) is seeking to renew its license for Clarivate MetaCore and MetaDrug software. The software is a web-based bioinformatics suite that allows researchers to upload data analysis results and provides functional analysis to identify relevant pathways, networks, and cellular processes. The software will be used by the Agency for Toxic Substances and Disease Registry (ATSDR) to support ongoing computational systems biology and toxicological research activities. The contract will be for a period of 5 years, from August 18, 2026, to August 17, 2031.
• The software will be used for computational systems biology and bioinformatics analysis.
• The software will provide functional analysis to identify relevant pathways, networks, and cellular processes.
• The software will be used to support ongoing research activities, including toxicogenomics and environmental health research.
• The contract will include requirements for information security and privacy, including compliance with Section 508 accessibility standards.
• The contract will include requirements for reporting and incident response, including notification of breaches and incidents.